These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 9851894)
1. alpha2-macroglobulin and C1-inactivator are plasma inhibitors of human glandular kallikrein. Heeb MJ; España F Blood Cells Mol Dis; 1998 Dec; 24(4):412-9. PubMed ID: 9851894 [TBL] [Abstract][Full Text] [Related]
2. Detection of human glandular kallikrein, hK2, as its precursor form and in complex with protease inhibitors in prostate carcinoma serum. Grauer LS; Finlay JA; Mikolajczyk SD; Pusateri KD; Wolfert RL J Androl; 1998; 19(4):407-11. PubMed ID: 9733142 [TBL] [Abstract][Full Text] [Related]
3. Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid. Charlesworth MC; Young CY; Miller VM; Tindall DJ J Androl; 1999; 20(2):220-9. PubMed ID: 10232657 [TBL] [Abstract][Full Text] [Related]
4. Identification of a novel complex between human kallikrein 2 and protease inhibitor-6 in prostate cancer tissue. Mikolajczyk SD; Millar LS; Marker KM; Rittenhouse HG; Wolfert RL; Marks LS; Charlesworth MC; Tindall DJ Cancer Res; 1999 Aug; 59(16):3927-30. PubMed ID: 10463585 [TBL] [Abstract][Full Text] [Related]
5. Measurement of prostate-specific antigen and human glandular kallikrein 2 in different body fluids. Lövgren J; Valtonen-André C; Marsal K; Lilja H; Lundwall A J Androl; 1999; 20(3):348-55. PubMed ID: 10386814 [TBL] [Abstract][Full Text] [Related]
6. Prostate specific antigen-alpha 2-macroglobulin complexes in prostate cancer patient sera. Heeb MJ; España F; Gittes RF; Griffin JH Biochem Mol Biol Int; 1995 Nov; 37(5):917-23. PubMed ID: 8624498 [TBL] [Abstract][Full Text] [Related]
7. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma. Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Lümmen G; Wernli M; Wiefelspütz J; Graber SF; Goepel M; Huber A; Tscholl R Cancer; 1998 Dec; 83(12):2540-7. PubMed ID: 9874461 [TBL] [Abstract][Full Text] [Related]
8. Western blot analyses of prekallikrein and its activation products in human plasma. Veloso D; Colman RW Thromb Haemost; 1991 Apr; 65(4):382-8. PubMed ID: 1711719 [TBL] [Abstract][Full Text] [Related]
9. Expression of human prostate-specific glandular kallikrein protein (hK2) in the breast cancer cell line T47-D. Hsieh ML; Charlesworth MC; Goodmanson M; Zhang S; Seay T; Klee GG; Tindall DJ; Young CY Cancer Res; 1997 Jul; 57(13):2651-6. PubMed ID: 9205072 [TBL] [Abstract][Full Text] [Related]
10. Prostate-specific kallikreins-2 and -4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and -2. Mize GJ; Wang W; Takayama TK Mol Cancer Res; 2008 Jun; 6(6):1043-51. PubMed ID: 18567807 [TBL] [Abstract][Full Text] [Related]
11. Identification of human glandular kallikrein hK2 from LNCaP cells. Grauer LS; Charlesworth MC; Saedi MS; Finlay JA; Liu RS; Kuus-Reichel K; Young CY; Tindall DJ J Androl; 1996; 17(4):353-9. PubMed ID: 8889697 [TBL] [Abstract][Full Text] [Related]
12. High molecular weight kininogen potentiates the heparin-accelerated inhibition of plasma kallikrein by antithrombin: role for antithrombin in the regulation of kallikrein. Olson ST; Sheffer R; Francis AM Biochemistry; 1993 Nov; 32(45):12136-47. PubMed ID: 7692967 [TBL] [Abstract][Full Text] [Related]
13. Inactivation of kallikrein in human plasma. van der Graaf F; Koedam JA; Bouma BN J Clin Invest; 1983 Jan; 71(1):149-58. PubMed ID: 6184384 [TBL] [Abstract][Full Text] [Related]
14. Serum human glandular kallikrein 2 (hK2) for distinguishing stage and grade of prostate cancer. Stephan C; Jung K; Nakamura T; Yousef GM; Kristiansen G; Diamandis EP Int J Urol; 2006 Mar; 13(3):238-43. PubMed ID: 16643616 [TBL] [Abstract][Full Text] [Related]
15. Potential involvement of kallikrein hK2 in the hydrolysis of the human seminal vesicle proteins after ejaculation. Deperthes D; Frenette G; Brillard-Bourdet M; Bourgeois L; Gauthier F; Tremblay RR; Dubé JY J Androl; 1996; 17(6):659-65. PubMed ID: 9016396 [TBL] [Abstract][Full Text] [Related]
16. Free and total human glandular kallikrein 2 in patients with prostate cancer. Väisänen V; Pettersson K; Alanen K; Viitanen T; Nurmi M Urology; 2006 Jul; 68(1):219-25. PubMed ID: 16844459 [TBL] [Abstract][Full Text] [Related]
17. Human glandular kallikrein, hK2, shows arginine-restricted specificity and forms complexes with plasma protease inhibitors. Mikolajczyk SD; Millar LS; Kumar A; Saedi MS Prostate; 1998 Jan; 34(1):44-50. PubMed ID: 9428387 [TBL] [Abstract][Full Text] [Related]
18. Purification of enzymatically active kallikrein hK2 from human seminal plasma. Frenette G; Deperthes D; Tremblay RR; Lazure C; Dubé JY Biochim Biophys Acta; 1997 Feb; 1334(1):109-15. PubMed ID: 9042371 [TBL] [Abstract][Full Text] [Related]
19. Cold promoted activation and factor XII, prekallikrein and C1-inhibitor. Czendlik C; Lämmle B; Duckert F Thromb Haemost; 1985 Apr; 53(2):242-4. PubMed ID: 2410997 [TBL] [Abstract][Full Text] [Related]
20. Plasma prekallikrein assay: reversible inhibition of C-1 inhibitor by chloroform and its use in measuring prekallikrein in different mammalian species. Schmaier AH; Gustafson E; Idell S; Colman RW J Lab Clin Med; 1984 Dec; 104(6):882-92. PubMed ID: 6209352 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]